AAV-Navβ1 gene therapy effectively reduces seizures and prolongs life in a mouse model of SCN1B-linked Dravet syndrome, ...

Ultra-Powered MRI Scans Show Damage to Brain's 'Control Center' Is Behind Long-Lasting COVID-19 Symptoms Oct. 8, 2024 — Damage to the brainstem -- the brain's 'control center' -- is behind long ...

WHEN a 44-year-old man began experiencing a common symptom experienced by millions, he decided to get checked out by medical ...

Brain metastases from prostate cancer ... visual disturbances or ataxia, which may be confused with symptoms of ischemic or hemorrhagic events. However, a correct differential diagnosis can ...

Anyone suffering from HAPE must be evacuated to a medical facility for proper follow-up treatment. HACE is the result of swelling of brain tissue from fluid leakage. Symptoms can include headache, ...

Jan. 28, 2025 — A new study shows that asymptomatic brain metastasis is more common in stage 4 breast cancer patients than previously believed. The study suggests ... Route of Entry for Semliki ...

Nearly 90% of them are fatal. This article explores what happens when cardiac arrest causes brain damage due to a lack of oxygen, and the common symptoms seen when a person is revived. It also looks ...

"We are excited to be one step closer to bringing an approved therapy to all patients with Friedreich's ataxia," said Matthew ... and neuromuscular disease symptoms. About MOVE-FA MOVE-FA was ...

During the later stages, symptoms are more often the result of opportunistic infections that occur when the virus progressively destroys the immune system and leaves it vulnerable to diseases that can ...

A few case reports have described CHS development in patients with large cerebral aneurysm treated by stent assisted coiling or flow diverter.52 53 Therefore, larger series are required to clarify the ...

"Drivers must understand the nature of not disclosing medical conditions to the DVLA. Beyond the risk of fines, failure to ...

The company will discontinue development of its original ALS gene therapy candidate VY9323 amid toxic effects in nonhuman ...